Shree Pacetronix share price
BSE: 527005Healthcare Equipment & SuppliesSmall Cap
Last close ₹158.10down ₹9.85 (5.86%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹167.95.
52-week range of traded prices to 23 Oct 2026
₹90.00Low, 30 Mar 2026₹283.15High, 28 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹59 Cr3,439th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 18.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 25 May 2026
- 3.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 20.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 21.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 25 May 2026
- 0.15
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,405
Results
Consolidated; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 13 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹4.90 Crdown 8.77%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹0.76 Crdown 31.99%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 15.4%
Revenue by year
Peak revenue ₹22 Cr, year to Mar 2024
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 1 of the 10 years shown
| ₹ crore | Sep 2024Filed 11 Nov | Dec 2024Filed 29 Jan | Mar 2025Filed 13 Jun | Jun 2025Filed 7 Aug | Sep 2025Filed 1 Nov | Dec 2025Filed 13 Feb | Mar 2026Filed 25 May | Jun 2026Filed 13 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.04 | 3.63 | 4.28 | 5.34 | 6.59 | 4.33 | 5.37 | 4.90 |
| Net profit | 0.03 | −0.11 | 0.45 | 0.66 | 1.31 | 0.06 | 1.11 | 0.76 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 0.8% | −3.1% | 10.6% | 12.4% | 19.9% | 1.3% | 20.7% | 15.4% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, Life Saving Devices, which carries all its revenue.
Valuation
Today, against the company's own history. Dividend yield is not shown: no dividend in the years on record.PE ratio and valuation history
Price to earningsPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
At or below today's level on 33% of 1,137 trading days over the last 5 years.
LowestHighest
Its median20.4Industry median22.0
Price to bookPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
At or below today's level on 42% of 1,137 trading days over the last 5 years.
LowestHighest
Its median3.7Industry median2.5
EV to EBITDAEnterprise value to EBITDA. Market cap plus borrowings less cash and bank balances, divided by operating profit before depreciation (revenue less operating expenses, without other income and one-off items) over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly): what the whole business costs against the profit its operations make. Lease liabilities are not counted: the results filings do not state them.11.5
At or below today's level on 48% of 1,137 trading days over the last 5 years.
LowestHighest
Its median11.7Industry median16.4
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +46.9% | +302.4% | −63.5% | 0.0% |
| 3 years | −2.1% | −2.5% | +0.4% | 0.0% |
| 5 years | +51.2% | +124.4% | −32.6% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 1, 3 and 5 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Peers and competitors
Medical Equipment & Supplies, 27 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Shree Pacetronix in market cap. 1 company in the table last traded before then: its row is priced on its last trade.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 EarkartEARKART | 164 | 33.2 | 2.5 | 17.0 | – | – | 7.7% | 12.0% | 0.00% |
 Vaidya Sane Ayurved LaboratoriesMADHAVBAUG | 154 | 17.1 | 2.1 | – | +19.0% | +34.9% | 13.4% | – | 0.00% |
| Avience BiomedicalsAVIENCE | 132 | 15.0 | – | – | – | – | 27.9% | – | 0.00% |
 Choksi AsiaCHOKSI | 113 | 21.8 | 2.7 | 16.0 | +21.4% | – | 13.1% | 14.7% | 0.00% |
 Mohini Health & HygieneMHHL | 52 | – | 0.6 | – | −13.9% | −382.3% | −17.2% | – | 0.00% |
 Amkay ProductsAMKAY | 46 | 20.0 | 1.8 | – | +9.5% | −30.8% | 9.2% | – | 0.00% |
 Royal SenseROYAL | 37 | 5.2 | 0.9 | – | +67.5% | +13.0% | 21.0% | – | 0.00% |
 GKB OphthalmicsGKB | 30 | 9.3 | 0.6 | 3.6 | +29.9% | – | 6.2% | 10.5% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
| Ex-date | Type | Per share |
|---|---|---|
| 24 Sep 2007 | Final | ₹0.50 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
Sep 2026
Shree Pacetronix share price by year
Each calendar year to 2025.Shree Pacetronix share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 189.80 | +51.8% | 279.70 | 62.31 |
| 2024 | 125.00 | −42.3% | 255.75 | 113.60 |
| 2023 | 216.75 | +113.0% | 391.00 | 87.70 |
| 2022 | 101.75 | +263.4% | 188.30 | 16.70 |
| 2021 | 28.00 | +133.3% | 31.40 | 8.74 |
| 2020 | 12.00 | 0.0% | 13.23 | 10.84 |
| 2019 | 12.00 | −2.0% | 12.86 | 12.00 |
| 2018 | 12.25 | +3.9% | 13.23 | 11.69 |
| 2017 | 11.79 | +17.9% | 12.07 | 8.92 |
| 2016 | 10.00 | −45.1% | 18.00 | 9.98 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2019 is from its first session, 29 Mar 2019. 2016 is from its first session, 22 Jan 2016. The close is the year's last trade for 2019 (26 Nov 2019), 2017 (19 Dec 2017) and 2016 (28 Nov 2016).
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 174.80 | 174.80 | 149.30 | 158.10 | 157.12 | 1,405 |
| 22 Oct 2026 | 155.10 | 167.95 | 150.95 | 167.95 | 159.67 | 1,548 |
| 21 Oct 2026 | 162.00 | 168.80 | 155.15 | 159.45 | 161.57 | 3,275 |
| 19 Oct 2026 | 158.00 | 169.95 | 155.50 | 161.75 | 160.18 | 964 |
| 16 Oct 2026 | 169.90 | 169.90 | 161.00 | 164.00 | 165.11 | 912 |
| 15 Oct 2026 | 170.00 | 170.00 | 162.55 | 165.45 | 165.89 | 390 |
| 14 Oct 2026 | 169.95 | 177.70 | 160.20 | 169.20 | 170.04 | 1,789 |
| 13 Oct 2026 | 173.25 | 173.25 | 162.20 | 165.60 | 166.74 | 847 |
| 12 Oct 2026 | 179.75 | 183.80 | 168.20 | 174.90 | 177.11 | 1,511 |
| 9 Oct 2026 | 171.75 | 171.75 | 162.20 | 168.20 | 166.79 | 692 |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Shree Pacetronix Ltd
- BSE code
- 527005
- ISIN
- INE847D01010
- Industry
- Healthcare Equipment & Supplies
- Listed
- Nov 1993
- Face value
- ₹10
- CIN
- L33112MP1988PLC004317
- Corporate identity number, the registrar of companies' code for it